SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cardiac Science Inc. DFIB (NASDAQ)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Marc Phelan who wrote (77)4/16/2002 10:02:47 PM
From: Skywatcher  Read Replies (1) of 174
 
Cardiac Science Granted Additional U.S. and European
Patents Covering Defibrillator Technologies

Company Intellectual Property Portfolio Now Stands at 64 Issued
Patents

IRVINE, Calif., April 16 /PRNewswire-FirstCall/ -- Cardiac Science, Inc. (Nasdaq: DFIB -
news) today announced it has been granted two additional U.S. patents and a European
patent covering technology embodied in its Powerheart® Automatic External Defibrillator
(AED), its Powerheart® CRM(TM) and its wearable defibrillator product, bringing the total
of the Company's issued patents to 64 and further strengthening its intellectual property
portfolio. The U.S. Patents cover an AED battery status indicator and the remote collection
of information from a wearable defibrillator; the European patent extends the protection of the
Company's proprietary biphasic energy waveform to Europe. Cardiac Science has filed
approximately 10 additional patents, which are pending, related to its technology platform
and applications in both hospital and public access defibrillator products.

At least the good news keeps comin
CC
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext